Screener
Myriad Genetics MYGN Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
Based on the most recent quarter.
The source filing: Myriad Genetics’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 6:05 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000899923-26-000038
FAQ
- What is Myriad Genetics's current ratio?
- Myriad Genetics (MYGN) reported current ratio of 2.4× in Q1 2026.
- How has Myriad Genetics's current ratio changed year-over-year?
- Myriad Genetics's current ratio increased by 26.4% year-over-year, from 1.9× to 2.4×.
- What is the long-term trend for Myriad Genetics's current ratio?
- Over 5 years (2020 to 2025), Myriad Genetics's current ratio has grown at a -1.4% compound annual growth rate (CAGR), from 2.7× to 2.5×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Myriad Genetics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude